{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:31:44Z","timestamp":1793028704236,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xphs.2026.104241","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:04:53Z","timestamp":1772899493000},"page":"104241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intranasal delivery of chitosan-coated bilosomes for repurposing Olmesartan in Alzheimer\u2019s disease therapy: Formulation, optimization, pharmacokinetic and pharmacodynamic evaluation"],"prefix":"10.1016","volume":"115","author":[{"given":"Ghada Abdelsabour","family":"Moubarak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-2645","authenticated-orcid":false,"given":"Alaa H.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1328-5987","authenticated-orcid":false,"given":"Adel A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa F.","family":"Galal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-4619","authenticated-orcid":false,"given":"Shahinaze A.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-8602","authenticated-orcid":false,"given":"Hussein M.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/ph15030281","article-title":"Lipid nanocarriers overlaid with chitosan for brain delivery of berberine via the nasal route","volume":"15","author":"Abo El-Enin","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.xphs.2026.104241_bib0002","article-title":"Intranasal Apocynin-loaded nanostructured lipid carriers (NLCs) for Alzheimer's disease therapy: formulation, optimization, and pharmacokinetic evaluations","volume":"108","author":"Samala","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0003","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"2-3","key":"10.1016\/j.xphs.2026.104241_bib0004","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejphar.2011.09.019","article-title":"Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo","volume":"670","author":"Paris","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.xphs.2026.104241_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer\u2019s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.xphs.2026.104241_bib0006","series-title":"Oxidative Stress in Alzheimer\u2019s Disease: Molecular Hallmarks of Underlying Vulnerability. Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease: Non-Pharmacological Therapies for Alzheimer's Disease","first-page":"91","author":"Uddin","year":"2019"},{"key":"10.1016\/j.xphs.2026.104241_bib0007","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","article-title":"Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review","volume":"351","author":"Elkomy","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2026.104241_bib0008","article-title":"Novel nasal niosomes loaded with lacosamide and coated with chitosan: a possible pathway to target the brain to control partial-onset seizures","volume":"6","author":"Tulbah","year":"2023","journal-title":"Int J Pharm: X"},{"issue":"8","key":"10.1016\/j.xphs.2026.104241_bib0009","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3390\/pharmaceutics15082095","article-title":"Intranasal nanotransferosomal gel for quercetin brain targeting: II. Antidepressant effect in an experimental animal model","volume":"15","author":"Elkomy","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104241_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2024.08.026","article-title":"Brain targeting of venlafaxine via intranasal transbilosomes thermogel for improved management of depressive disorder","author":"Alsaidan","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104241_bib0011","first-page":"1","article-title":"Intranasal trimethyl chitosan-coated emulsomes containing tizanidine as brain-targeted therapy in spasticity: formulation, optimization, and pharmacokinetic assessment","author":"Elkomy","year":"2024","journal-title":"Drug Deliv Transl Res"},{"issue":"11","key":"10.1016\/j.xphs.2026.104241_bib0012","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/pharmaceutics13111828","article-title":"Intranasal zolmitriptan-loaded bilosomes with extended nasal mucociliary transit time for direct nose to brain delivery","volume":"13","author":"El Taweel","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0013","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.xphs.2021.11.007","article-title":"Harnessing of doxylamine succinate\/pyridoxine hydrochloride-dual laden bilosomes as a novel combinatorial nanoparadigm for intranasal delivery: in vitro optimization and in vivo pharmacokinetic appraisal","volume":"111","author":"Salem","year":"2022","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0014","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1080\/10717544.2022.2110997","article-title":"Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats","volume":"29","author":"Elkomy","year":"2022","journal-title":"Drug Deliv"},{"issue":"7","key":"10.1016\/j.xphs.2026.104241_bib0015","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/acschemneuro.0c00775","article-title":"Olmesartan prevents oligomerized amyloid \u03b2 (A\u03b2)-induced cellular senescence in neuronal cells","volume":"12","author":"Wang","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0016","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/1440-1681.13738","article-title":"Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats","volume":"50","author":"Rodriguez-Ortiz","year":"2023","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"10.1016\/j.xphs.2026.104241_bib0017","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuropharm.2007.08.020","article-title":"Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan","volume":"53","author":"Mogi","year":"2007","journal-title":"Neuropharmacology"},{"issue":"13-14","key":"10.1016\/j.xphs.2026.104241_bib0018","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3109\/02699050903379404","article-title":"Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients","volume":"23","author":"Matsumoto","year":"2009","journal-title":"Brain Inj"},{"key":"10.1016\/j.xphs.2026.104241_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101612","article-title":"Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer\u2019s disease: past, present and future","volume":"77","author":"Gouveia","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.xphs.2026.104241_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102698","article-title":"Repurposing drugs: promising therapeutic approach against Alzheimer\u2019s disease","volume":"106","author":"Pattanaik","year":"2025","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.xphs.2026.104241_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149777","article-title":"Trophic factors and essential oils as potential neuromodulators of Renin-Angiotensin system","volume":"1863","author":"Crespo","year":"2025","journal-title":"Brain Res"},{"key":"10.1016\/j.xphs.2026.104241_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2026.111635","article-title":"Ang II-mediated effects on BBB integrity in psychiatric and neurological disorders","volume":"145","author":"Hatho Towo","year":"2026","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.xphs.2026.104241_bib0023","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neuroscience.2025.05.308","article-title":"Neurochemical exploration for therapeutic advancements in stroke","volume":"579","author":"Barik","year":"2025","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.xphs.2026.104241_bib0024","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.avsg.2010.03.023","article-title":"Protective effects of angiotensin II Type-1 receptor blockade with olmesartan on spinal cord ischemia-reperfusion injury: an experimental study on rats","volume":"24","author":"G\u00fcler","year":"2010","journal-title":"Ann Vasc Surg"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2011.07.041","article-title":"Modulation of AT-1R\/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice","volume":"348","author":"Lakshmanan","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104241_bib0026","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.109.138586","article-title":"Angiotensin receptor blocker prevented \u03b2-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling","volume":"54","author":"Takeda","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.xphs.2026.104241_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/polym15061464","article-title":"Oral delivery of psoralidin by mucoadhesive surface-modified bilosomes showed boosted apoptotic and necrotic effects against breast and lung cancer cells","volume":"15","author":"Youness","year":"2023","journal-title":"Polymers"},{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0028","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/pharmaceutics14030563","article-title":"Surface-modified bilosomes nanogel bearing a natural plant alkaloid for safe management of rheumatoid arthritis inflammation","volume":"14","author":"Elkomy","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.xphs.2026.104241_bib0029","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/pharmaceutics13081197","article-title":"Berberine encapsulated lecithin\u2013chitosan nanoparticles as innovative wound healing agent in type II diabetes","volume":"13","author":"Panda","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104241_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107078","article-title":"Nose-to-brain delivery of chitosan coated leciplex containing zopiclone for improved management of epilepsy: formulation, pharmacokinetics, and pharmacodynamics","author":"Eid","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"10.1016\/j.xphs.2026.104241_bib0031","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.xphs.2024.03.027","article-title":"A Novel chitosan-coated leciplex loaded with ambrisentan as a possible pulmonary nanosystem: optimization, characterization, and pharmacokinetics assessments","volume":"113","author":"Eid","year":"2024","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104241_bib0032","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/pharmaceutics14071374","article-title":"Intranasal delivery of granisetron to the brain via nanostructured cubosomes-based in situ gel for improved management of chemotherapy-induced emesis","volume":"14","author":"Eissa","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104241_bib0033","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2147\/IJN.S342504","article-title":"Potential use of tailored citicoline chitosan-coated liposomes for effective wound healing in diabetic rat model","author":"Eid","year":"2022","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2026.104241_bib0034","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13346-018-0499-3","article-title":"Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer","volume":"8","author":"Salem","year":"2018","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2026.104241_bib0035","article-title":"Nose-to-brain delivery of chitosan-grafted leciplexes for promoting the bioavailability and antidepressant efficacy of mirtazapine","volume":"18","author":"El Sisi","year":"2025"},{"issue":"7","key":"10.1016\/j.xphs.2026.104241_bib0036","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3109\/10717544.2015.1013587","article-title":"Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation","volume":"23","author":"Aboud","year":"2016","journal-title":"Drug Deliv"},{"issue":"4","key":"10.1016\/j.xphs.2026.104241_bib0037","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/03639045.2016.1268153","article-title":"Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic\u2013pharmacodynamic modeling approach for quantitative prediction of skin absorption","volume":"43","author":"Elkomy","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2026.104241_bib0038","article-title":"Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study","volume":"54","author":"Eid","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0039","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10123-024-00534-6","article-title":"The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects","volume":"28","author":"Youssef","year":"2025","journal-title":"Int Microbiol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0040","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1080\/10717544.2022.2120925","article-title":"Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach","volume":"29","author":"Kharouba","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2026.104241_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1371-6","article-title":"Development, optimization, and in vitro\/in vivo characterization of enhanced lipid nanoparticles for ocular delivery of ofloxacin: the influence of pegylation and chitosan coating","volume":"20","author":"Eid","year":"2019","journal-title":"AAPS Pharmscitech"},{"issue":"8","key":"10.1016\/j.xphs.2026.104241_bib0042","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.xphs.2021.04.020","article-title":"Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin","volume":"110","author":"Eid","year":"2021","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104241_bib0043","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1080\/10717544.2016.1176086","article-title":"Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling","volume":"23","author":"Elkomy","year":"2016","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0044","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.xphs.2021.11.007","article-title":"Harnessing of doxylamine succinate\/pyridoxine hydrochloride-dual laden bilosomes as a novel combinatorial nanoparadigm for intranasal delivery: in vitro optimization and in vivo pharmacokinetic appraisal","volume":"111","author":"Salem","year":"2022","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/03639045.2020.1871005","article-title":"Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis","volume":"47","author":"Elkomy","year":"2021","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2026.104241_bib0046","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/pharmaceutics15071805","article-title":"Intranasal nanotransferosomal gel for quercetin brain targeting: I. Optimization, characterization, brain localization, and cytotoxic studies","volume":"15","author":"Elkomy","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104241_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122278","article-title":"Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: pharmacokinetic and pharmacodynamic perspectives","volume":"628","author":"Hassan","year":"2022","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0048","first-page":"8","article-title":"Formulation and evaluation of meloxicam orally dispersible capsules","volume":"4","author":"El-Mahrouk","year":"2009","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0049","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/10717544.2017.1357148","article-title":"Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation","volume":"24","author":"Fatouh","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2026.104241_bib0050","article-title":"Sustained release olmesartan medoxomil loaded PLGA nanoparticles with improved oral bioavailability to treat hypertension","volume":"55","author":"Si","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2026.104241_bib0051","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.colsurfb.2017.03.006","article-title":"Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability","volume":"154","author":"Kaithwas","year":"2017","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.xphs.2026.104241_bib0052","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/pharmaceutics14040863","article-title":"Fabrication and in vitro\/in vivo appraisal of metronidazole intra-gastric buoyant sustained-release tablets in healthy volunteers","volume":"14","author":"Elkomy","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104241_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-5-37","article-title":"Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation","volume":"5","author":"Lee","year":"2008","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.xphs.2026.104241_bib0054","first-page":"269","article-title":"Inhibitory effects of valproate on impairment of Y-maze alternation behavior induced by repeated electroconvulsive seizures and c-Fos protein levels in rat brains","volume":"65","author":"Hidaka","year":"2011","journal-title":"Acta Med Okayama"},{"issue":"53","key":"10.1016\/j.xphs.2026.104241_bib0055","first-page":"2920","article-title":"Morris water maze test for learning and memory deficits in Alzheimer's disease model mice","author":"Bromley-Brits","year":"2011","journal-title":"J Vis Exp: JoVE"},{"issue":"19","key":"10.1016\/j.xphs.2026.104241_bib0056","first-page":"897","article-title":"Morris water maze experiment","author":"Nunez","year":"2008","journal-title":"J Vis Exp: JoVE"},{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0057","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1254\/jjp.87.195","article-title":"Deterioration of spatial learning performances in lipopolysaccharide-treated mice","volume":"87","author":"Arai","year":"2001","journal-title":"Jpn J Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0058","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","article-title":"Determination of malonaldehyde precursor in tissues by thiobarbituric acid test","volume":"86","author":"Uchiyama","year":"1978","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0059","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0003-2697(78)90350-0","article-title":"Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparations","volume":"86","author":"Gorun","year":"1978","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0060","first-page":"149","article-title":"ImmunoMax. A maximized immunohistochemical method for the retrieval and enhancement of hidden antigens","volume":"73","author":"Merz","year":"1995","journal-title":"Lab Investig; J Tech Methods Pathol"},{"key":"10.1016\/j.xphs.2026.104241_bib0061","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"issue":"11","key":"10.1016\/j.xphs.2026.104241_bib0062","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1080\/03639045.2018.1504963","article-title":"Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box\u2013Behnken statistical design","volume":"44","author":"Salem","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2026.104241_bib0063","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/10837450.2014.926919","article-title":"Transdermal delivery of meloxicam using niosomal hydrogels: in vitro and pharmacodynamic evaluation","volume":"20","author":"El-Badry","year":"2015","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0064","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","article-title":"Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation","volume":"30","author":"Khallaf","year":"2020","journal-title":"J Liposome Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0065","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/10717544.2019.1686087","article-title":"Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund's adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway","volume":"26","author":"El Menshawe","year":"2019","journal-title":"Drug deliv"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0066","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13346-019-00688-1","article-title":"A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation","volume":"10","author":"El Menshawe","year":"2020","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0067","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/10717544.2016.1228718","article-title":"Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage","volume":"24","author":"Avadhani","year":"2017","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08982104.2014.950276","article-title":"Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett\u2013Burman design and characterization","volume":"25","author":"Ahmed","year":"2015","journal-title":"J Liposome Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104241_bib0069","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2013.07.060","article-title":"Glycerosomes: a new tool for effective dermal and transdermal drug delivery","volume":"455","author":"Manca","year":"2013","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104241_bib0070","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","article-title":"Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment","volume":"513","author":"Abdelbary","year":"2016","journal-title":"Int J Pharm"},{"issue":"sup1","key":"10.1016\/j.xphs.2026.104241_bib0071","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/21691401.2018.1443117","article-title":"Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation","volume":"46","author":"Janga","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104241_bib0072","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/08982104.2012.700460","article-title":"Brain delivery of olanzapine by intranasal administration of transfersomal vesicles","volume":"22","author":"Salama","year":"2012","journal-title":"J Liposome Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0073","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(03)00254-0","article-title":"Chitosan-coated liposomes: characterization and interaction with leuprolide","volume":"260","author":"Guo","year":"2003","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0074","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejpb.2010.03.014","article-title":"Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers","volume":"75","author":"Hasanovic","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2026.104241_bib0075","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s11947-013-1160-2","article-title":"Quercetin-loaded lecithin\/chitosan nanoparticles for functional food applications","volume":"7","author":"Souza","year":"2014","journal-title":"Food Bioprocess Technol"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104241_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.05.029","article-title":"Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: in-vitro, ex-vivo and in-vivo evaluation","volume":"527","author":"Abdellatif","year":"2017","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0077","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2013.07.031","article-title":"Nano-transfersomes as a novel carrier for transdermal delivery","volume":"454","author":"Chaudhary","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0078","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/pharmaceutics12010025","article-title":"Spironolactone-loaded leciplexes as potential topical delivery systems for female acne: in vitro appraisal and ex vivo skin permeability studies","volume":"12","author":"Salama","year":"2019","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2026.104241_bib0079","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.fjps.2017.04.001","article-title":"Olmesartan medoxomil-loaded mixed micelles: preparation, characterization and in-vitro evaluation","volume":"3","author":"El-Gendy","year":"2017","journal-title":"Future J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104241_bib0080","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3390\/pharmaceutics14102215","article-title":"Sertaconazole-nitrate-loaded leciplex for treating keratomycosis: optimization using D-optimal design and in vitro, ex vivo, and in vivo studies","volume":"14","author":"Abdellatif","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.xphs.2026.104241_bib0081","first-page":"1847","article-title":"Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide\/protein-based therapeutics or vaccines","volume":"23","author":"Aburahma","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2026.104241_bib0082","first-page":"4331","article-title":"Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application","author":"Mahmood","year":"2014","journal-title":"Int J Nanomed"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104241_bib0083","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2013.11.028","article-title":"Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study","volume":"460","author":"Niu","year":"2014","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104241_bib0084","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2015.03.033","article-title":"Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam","volume":"485","author":"Al-Mahallawi","year":"2015","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0085","first-page":"199","article-title":"Olmesartan medoxomil-loaded niosomal gel for buccal delivery: formulation, optimization, and ex vivo studies","volume":"21","author":"Palei","year":"2024","journal-title":"Turk J Pharm Sci"},{"issue":"18","key":"10.1016\/j.xphs.2026.104241_bib0086","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.3390\/molecules29184421","article-title":"Optimization and synthesis of nano-niosomes for encapsulation of triacontanol by Box\u2013Behnken design","volume":"29","author":"Solano","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0087","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/pharmaceutics14010112","article-title":"Formulation of nano\/micro-carriers loaded with an enriched extract of coffee silverskin: physicochemical properties, in vitro release mechanism and in silico molecular modeling","volume":"14","author":"Fathi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104241_bib0088","doi-asserted-by":"crossref","first-page":"9783","DOI":"10.2147\/IJN.S278688","article-title":"Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation","volume":"15","author":"Ahmed","year":"2020","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.xphs.2026.104241_bib0089","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/pharmaceutics16010090","article-title":"Cross-linked alginate dialdehyde\/chitosan hydrogel encompassing curcumin-loaded bilosomes for enhanced wound healing activity","volume":"16","author":"Sideek","year":"2024","journal-title":"Pharmaceutics"},{"issue":"14","key":"10.1016\/j.xphs.2026.104241_bib0090","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3390\/polym13142272","article-title":"Design of olmesartan medoxomil-loaded nanosponges for hypertension and lung cancer treatments","volume":"13","author":"Almutairy","year":"2021","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.xphs.2026.104241_bib0091","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/10717544.2014.896428","article-title":"Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study","volume":"22","author":"Rahman","year":"2015","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1016\/j.xphs.2026.104241_bib0092","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.xphs.2022.10.001","article-title":"Budesonide-loaded bilosomes as a targeted delivery therapeutic approach against acute lung injury in rats","volume":"112","author":"Salem","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104241_bib0093","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1039\/dc9909000301","article-title":"Electroacoustic studies of moderately concentrated colloidal suspensions","volume":"90","author":"\u00e1O'Brien","year":"1990","journal-title":"Faraday Discuss Chem Soc"},{"issue":"4","key":"10.1016\/j.xphs.2026.104241_bib0094","first-page":"322","article-title":"Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: in-vitro and ex-vivo investigations","volume":"10","author":"Zubairu","year":"2015","journal-title":"Asian J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:21:22Z","timestamp":1776446482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022354926000900"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104241","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of chitosan-coated bilosomes for repurposing Olmesartan in Alzheimer\u2019s disease therapy: Formulation, optimization, pharmacokinetic and pharmacodynamic evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104241"}}